Open access peer-reviewed chapter

Cranberry Effects in Urinary Tract Infections

Written By

Gabriela Cimadon, Sabrina Barili, Alana da Silva and Beatriz Bonadiman

Submitted: 22 December 2022 Reviewed: 28 January 2023 Published: 28 March 2023

DOI: 10.5772/intechopen.1001309

From the Edited Volume

Edible Berries - New Insights

Nesibe Ebru Yaşa Kafkas and Hüseyin Çelik

Chapter metrics overview

390 Chapter Downloads

View Full Metrics

Abstract

Cranberry is scientifically known as Vaccinium macrocarpon, belongs to the family of Ericaceae, and grows in humid environments, such as forests and swamps in North American countries. It is widely used by Native American peoples and by Europeans as a food and also in traditional medicine for health benefits such as cardioprotective and anticarcinogenic properties and prevention of stomach ulcers. Some studies have demonstrated the potential against bacteria that reach the urinary tract and cause infections. According to the research by Salo, the fruit is composed of 88% water, acid organic, fruits, vitamin C, flavonoids, catechins, and anthocyanidins. It can be found in the form of dried fruits, extracts, and juices, which usually contain only 10 to 25% cranberry concentrate. In addition, it was revealed that anthocyanidins and the proanthocyanidins present in cranberry are tannins with a natural defense function against microorganisms, such as those responsible for urinary tract infections (UTI). This berry has a potential curative and preventive effect for various diseases, especially urinary tract infection. Therefore, it becomes relevant to clarify the effect of this natural product on urinary tract infections.

Keywords

  • natural product
  • treatment
  • infections
  • cranberry
  • urinary tract infections

1. Introduction

The American cranberry is one of the main native fruit cultures from North America. The so-called marvelous fruit, which belongs to the Ericaceae family and the species Vaccinium macrocarpon, has recently become the center of attention due to its significant therapeutic potential [1] and being a unique source that is rich in various bioactive classes, including flavonoids, anthocyanins, type A proanthocyanidins, polyphenols, carotenoids, and vitamins C and E [2].

This plant’s extract has been cultivated mainly for use in the industry as a meat preservative. In the medical industry, its main use is for wound healing, as well as to treat dental cavities and stomach ulcers, to prevent bacterial infections of the urinary tract caused by E. coli, and is likely to have anticancer properties. Several varieties of fungal pathogens are also susceptible to cultivated cranberry [3].

The daily consumption of a variety of fruit is recommended to keep healthy nutrition standards, to meet a suitable intake of micronutrients, and to promote the intake of a diversity of phytochemicals. Wild berries, including cranberries, represent a rich source of phenolic bio-actives that can contribute to human health [2].

Although they are not usually eaten raw, cranberries are available in a wide range of choices including juice and sauce, as well as dried fruit in cereal bars, cheese, chocolate, and other confectionary. All these choices of product are beneficial to health in a similar way and are easy to include in daily meals. Moreover, cranberry powder and extracts are now used in food and dietary supplements [2].

Advertisement

2. Effects of cranberry

Cranberry products have been used for centuries in popular medicine for the urinary tract health, and their antioxidant and antibacterial properties have been long reported [4, 5]. Cranberry’s biological activities are attributed to a diversified phytochemical profile with flavonoids such as flavonols, anthocyanins, and proanthocyanidins and catechins, phenolic acids, and triterpenoids [6].

The cranberry fruit has a vast class of phenolic compounds, responsible for its antioxidant activities. Chlorogenic acid and quercetin found in cranberry fruit are associated with a reduction in blood pressure, obesity, dyslipidaemia, and the effects of vasodilation improvement dependent on the endothelium [7, 8, 9].

Triterpenoids found in the wax of the cranberry fruit peel are associated with anti-inflammatory, anti-tumor, and anticancer activities [10, 11]. Previous studies have reported the efficacy of cranberry extracts to inhibit the growth and induction of apoptosis against different lineages of cancer cells, such as lung, ovarian, breast, prostate, and cervical cancer [4, 12, 13]. These antitumorigenic properties can be related with its antioxidant activity, which attenuates oxidative stress through the modulation of endogen enzymes and the reduction of oxidative markers [3, 14].

The polyphenols, anthocyanins, and proanthocyanidins found in cranberries act in the cell signaling pathways responsible for inflammation [4, 15]. The anti-inflammatory activity of cranberry products has been shown in the modulation of inflammatory markers of different inflammatory diseases such as colitis [16], hepatic inflammation [15], inflammatory intestinal disease [17], and pancreatic inflammation [14]. The administration of cranberry capsules standardized with proanthocyanidins has shown effect on the occurrence and severity of cystitis by radiation in prostate cancer patients [4].

Cranberries have been associated with the urinary tract health. Previous studies suggest that cranberry reduces urinary tract infections through negative regulation and interference on multiple virulence factors, which are associated with stress tolerance and microorganism survival in the urinary tract [18]. Cranberry products showed action against motility of the pathogens Pseudomonas aeruginosa, Escherichia coli, and Proteus mirabilis. Furthermore, a modulation of quorum sensing has been shown, which is a signaling pathway that influences several other bacterial virulence factors [19, 20, 21].

Bioactive compounds with selective antiviral activity in pathogenic bacteria can be extremely useful in the fight against bacterial infections caused by pathogens resistant to broad-spectrum antibiotics [20]. It has been shown that cranberries and propolis act to protect against adherence, motility, biofilm, and bacterial multiplication in the urinary tract when used as an alternative in the treatment for urinary tract infections by E. coli [22].

A number of studies have shown the potential of this species for pharmacological application directed to oral health. In this context, cranberry hydroalcoholic extracts inhibited the growth of six oral pathogenic microorganisms on the cariogenic, periodontal, endodontic, and candida order, namely, Streptococcus mutans, Lactobacillus acidophilus, P. gingivalis, Aggregatibacter actinomycetemcomitans, E. faecalis, and C. albicans [23, 24].

Cranberry products are associated with benefits to digestive health. They contain fibers and polyphenols related to the beneficial modulation in the gut microbiota, promoting the development of beneficial microorganisms, decreasing the occurrence of pathogenic microorganisms, and modulating the production of microbial metabolic products that help digestive health, such as short-chain fatty acids (SCFA) [16, 25, 26].

Proanthocyanidins are associated to the benefits against Helicobacter pylori infections, and the daily intake of cranberries is indicated for at least eight weeks [27].

Clinical studies with humans using cranberry products have focused mainly on the health of the urinary and cardiovascular tracts, oral health, and gastrointestinal epithelium [14] and have shown the high biotechnological potential of this species; however, it is still underestimated regarding other biological activities and therapeutic and pharmacological applications.

Advertisement

3. Cranberry effects on the treatment of urinary tract infections

Urinary tract infections (UTIs) are the most disseminated bacterial infections, and they represent a heavy economic and medical burden worldwide [28]. UTI is a pathology that predominates in all populations, even though women are the most affected. Approximately 50 to 70% of women have at least one episode of UTI during their lives, and 20 to 30% have recurring episodes [29].

In the majority of the infections of cystitis, 85%, the main etiological agent is E. coli (UPEC), but other microorganisms cause infections; Gram-negative bacteria Klebsiella pneumoniae and gram-positive coccus such as staphylococcus and enterococcus seem to be implicated in these infections [30, 31].

In Latin America, high percentages of E. coli strains were found to be resistant to fluoroquinolones (17.5–18.9%), ampicillin (61.4%), amoxicillin, clavulanic acid (18.6%), ceftriaxone (20.5%), gentamycin (25.0%), and trimethoprim/sulfamethoxazole (45%) [32].

It is important to point out that uropathogens can form biofilm to more easily adhere and increase their resistance. This affects the remaining microorganisms, causing higher adherence and multiplication, which may result in thick biofilms that significantly reduce the efficacy of antimicrobial treatments. When biofilm resources are limited, mature bacteria detach and can colonize a new surface to repeat the cycle [33].

Conventionally, the use of antibiotics to treat this pathology has been effective but may lead to resistance among uropathogens and other adverse side effects such as damage to gut microbiota. For these reasons, there is increasing interest in the search for natural therapies to prevent and treat UTIs to fight against the increase of bacterial resistance to antibiotics and the high recurrence rates [31, 34].

In these circumstances, one of the most studied alternative therapies against UTIs is the treatment with V. macrocarpon [32]. Salo et al. [35] have brought to light that anthocyanidins and proanthocyanidins found in cranberries are tannins with a natural defense function against microbial cells, and are a source of high-quality antioxidants.

Several clinical studies suggest that the intake of cranberry juice or cranberry supplements can reduce the occurrence of UTIs in healthy women [36, 37]. These observations were supported by the results of in vitro research, which show that compounds derived from cranberry (polyphenols and type A proanthocyanidins, for example) can interfere with bacterial adherence to epithelial cells of the urinary tract, attenuate the uropathogenic reservoir in the gastrointestinal tract, and suppress the inflammatory cascade [38, 39].

Among other possible mechanisms behind the protective effects of cranberries against UTIs is the ability of cranberry polyphenols to act as antiadhesive agents to prevent/inhibit the adherence of pathogens to uroepithelial cell receptors, which seems to be an important step in the pathogenesis of these infections [40].

As an alternative for the treatment of UTIs caused by E. coli, Ranfaig et al. [22] presented a study that assessed the levels of genome expression of this bacteria and measured them in the presence of cranberry and propolis products separately, and later compared with the non-treated isolate. They observed that cranberry along with propolis acted favoring protection against adherence, motility, biofilm, bacterial multiplication, and virulence of the urinary tract. Furthermore, the authors affirmed that the administration of both compounds was able to make the propolis intensify the action of cranberry, thus reaching the desired therapeutic effect.

Saramarasinghe et al. [41] performed a study with an isolate of E. coli CTXM-15, chosen due to its fast dissemination and resistance to some groups of antibiotics. It was submitted for analysis by qRT-PCR (quantitative reverse transcription-polymerase chain reaction) of the behavior of virulence factors after treatment with Cysticlean®, a cranberry product containing around 240 mg of proanthocyanidins.

The ten selected genes performed significant roles in normal cell functions such as iron absorption, toxin production, and stress survival in E. coli resistant to third-generation cephalosporin, and its relative genic expression was determined after exposure to Cysticlean® using qRT-PCR. Results showed that Cysticlean® significantly reduces the expression of a large variety of genes responsible for aptitude and virulence [41].

Two complementary mechanisms were suggested to explain the ability of American cranberry to reduce urinary tract infections. The first mechanism was credited to its biocide activity, which is made possible by the production of various elements that can damage the uropathogenic bacteria. Other mechanism to its antiviral activity through the negative regulation and interference with others virulence factors associated to stress tolerance and survival in the urinary tract [18].

Ventura [32] has shown the report of a patient who has suffered from recurring urinary infections for 20 years and made use of oral Ciprofloxacin for three days, later finding out they had E. coli following urine culture and resistance to the antibiotic they were using. Therefore, it was suggested to the patient to have treatment with cranberry extract.

The treatment described by Ventura [32] consisted of the intake of 5 g of the fruit, the equivalent amount to 18 mg of proanthocyanidins, dissolved in 250 mL of water, twice a day for 20 days, with follow-up attention. Six days after the end of treatment, the patient was asymptomatic, urine culture was normal, and antibiogram was negative. Thirteen weeks later, the patient was still asymptomatic, and urine cultures remained negative regarding bacterial growth.

Advertisement

4. Conclusion

The information obtained through the studied papers allows to conclude that the use of V. macrocarpon is an effective therapy in cases of urinary tract infections and has prophylactic action in cases of recurrent infections due to proanthocyanidins and anthocyanidins, which impair bacterial adherence to the urinary tract wall, and antiviral action that causes bacterial weakening and inactivation.

Finally, this natural product is promising for the treatment of urinary infections caused by gram-negative and -positive bacteria.

References

  1. 1. Jurikova T, Skrovankova S, Mlcek J, Balla S, Snopek L. Bioactive Compounds, Antioxidant Activity, and Biological Effects of European Cranberry (Vaccinium oxycoccos) . 2018;24:24. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337168/
  2. 2. Blumberg JB, Camesano TA, Cassidy A, Etherton PK, Howel A, Manach C, et al. Cranberries and their bioactive constituents in human health. Advances in Nutrition. 2013;4:618-632. DOI: 10.3945/an.113.004473
  3. 3. Rasool M, Malik A, Abdul Basit Ashraf M, Mubbin R, Ayyaz U, Waquar S, et al. Phytochemical analysis and protective effects of Vaccinium macrocarpon (cranberry) in rats (Rattus norvegicus) following ethylene oxide-induced oxidative insult. Bioengineered. 2021;12:4593-4604. DOI: 10.1080/21655979.2021.1955528
  4. 4. Hamilton K, Bennett NC, Purdie G, Herst PM. Standardized cranberry capsules for radiation cystitis in prostate cancer patients in New Zealand: A randomized double blinded, placebo controlled pilot study. Supportive Care in Cancer. 2015;23:95-102. DOI: 10.1007/s00520-014-2335-8
  5. 5. Das S. Natural therapeutics for urinary tract infections—A review. Future Journal of Pharmaceutical Sciences. 2020;2020:6. DOI: 10.1186/s43094-020-00086-2
  6. 6. Jurikova T, Skrovankova S, Mlcek J, Balla S, Snopek L. Bioactive compounds, antioxidant activity, and biological effects of European cranberry (vaccinium oxycoccos). Molecules. 2019;2019:24. DOI: 10.3390/molecules24010024
  7. 7. Sedbare R, Silina D, Janulis V. Evaluation of the Phytochemical Composition of Phenolic and Triterpene Compounds in Fruit of Large Cranberries (Vaccinium macrocarpon Aiton) Grown in Latvia Plants (Basileia). 2022;11(20): 2725. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609109/
  8. 8. Galvez J, Zevallos L, Velazquez D. Chlorogenic acid: Recent advances on its dual role as a food additive and a nutraceutical against metabolic syndrome. Molecules. 2017;22:358 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155416/
  9. 9. Pourmasoumi M, Hadi A, Najafgholizadeh A, Joukar F, Ghanaei F. The effects of cranberry on cardiovascular metabolic risk factors: A systematic review and meta-analysis. Clinical Nutrition. 2020;39:774-788. https://pubmed.ncbi.nlm.nih.gov/31023488/
  10. 10. Oszmiański J, Kolniak-Ostek J, Lachowicz S, Gorzelany J, Matlok N. Phytochemical compounds and antioxidant activity in different cultivars of cranberry (Vaccinium Macrocarpon L). Journal of Food Science. 2017;82:2569-2575. https://pubmed.ncbi.nlm.nih.gov/28973819/
  11. 11. Wu X, Xue L, Tata A, Song M, Neto C, Xiao H. Bioactive components of polyphenol-rich and non-polyphenol-rich cranberry fruit extracts and their Chemopreventive effects on colitis-associated Colon Cancer. Journal of Agricultural and Food Chemistry. 2020. https://pubmed.ncbi.nlm.nih.gov/32390426/
  12. 12. Wang Y, de B. Harrington P, Chen P. Analysis of phenolic compositions in cranberry dietary supplements using UHPLC-HRMS. Journal of Food Composition and Analysis. 2020;2020:86. DOI: 10.1016/j.jfca.2019.103362
  13. 13. Weh KM, Zhang Y, Howard CL, Howell AB, Clarke JL, Kresty LA. Cranberry polyphenols in Esophageal Cancer inhibition: New insights. Nutrients. 2022;2022:14. DOI: 10.3390/nu14050969
  14. 14. Santana DG, Oliveira AS, Souza MTDS, Santos JTDC, Hassimotto NMA, Silva AMDOE, et al. Vaccinium macrocarpon Aiton extract ameliorates inflammation and hyperalgesia through oxidative stress inhibition in experimental acute pancreatitis. Evidence-based Complementary and Alternative Medicine. 2018. DOI: 10.1155/2018/9646937
  15. 15. Glisan SL, Ryan C, Neilson AP, Lambert JD. Cranberry extract attenuates hepatic inflammation in high-fat-fed obese mice. Journal of Nutritional Biochemistry. 2016;37:60-66. DOI: 10.1016/j.jnutbio.2016.07.009
  16. 16. Cai X, Han Y, Gu M, Song M, Wu X, Li Z, et al. Dietary cranberry suppressed colonic inflammation and alleviated gut microbiota dysbiosis in dextran sodium sulfate-treated mice. Food & Function. 2019;10:6331-6341. DOI: 10.1039/c9fo01537j
  17. 17. Xiao X, Kim J, Sun Q , Kim D, Park CS, Lu TS, et al. Preventive effects of cranberry products on experimental colitis induced by dextran sulphate sodium in mice. Food Chemistry. 2015;167:438-446. DOI: 10.1016/j.foodchem.2014.07.006
  18. 18. Othman M. Is cranberry effective in preventing recurrent urinary tract infection in women. IOSR Journal of Pharmacy. 2016;2016:7-15
  19. 19. Hidalgo G, Chan M, Tufenkji N. Inhibition of Escherichia coli CFT073 flic expression and motility by cranberry materials. Applied and Environmental Microbiology. 2011;77:6852-6857. DOI: 10.1128/AEM.05561-11
  20. 20. Maisuria VB, Los Santos YL, Tufenkji N, Déziel E. Cranberry-derived proanthocyanidins impair virulence and inhibit quorum sensing of Pseudomonas aeruginosa. Scientific Reports. 2016;2016:6. DOI: 10.1038/srep30169
  21. 21. McCall J, Hidalgo G, Asadishad B, Tufenkji N. Cranberry impairs selected behaviors essential for virulence in Proteus mirabilis HI4320. Canadian Journal of Microbiology. 2013;59:430-436. DOI: 10.1139/cjm-2012-0744
  22. 22. Ranfaing J, Dunyach-Remy C, Louis L, Lavigne JP, Sotto A. Propolis potentiates the effect of cranberry (Vaccinium macrocarpon) against the virulence of uropathogenic Escherichia coli. Scientific Reports. 2018;2018:8. DOI: 10.1038/s41598-018-29082-6
  23. 23. Philip N, Walsh LJ. Cranberry polyphenols: Natural weapons against dental caries. Dental Journal (Basel). 2019;2019:7. DOI: 10.3390/dj7010020
  24. 24. Kumar V, Ankola A, Sankeshwari R, Jalihal S, Deepak V, Jois HS. Assessment of the antimicrobial efficacy of hydroalcoholic fruit extract of cranberry against Socransky complexes and predominant cariogenic, mycotic and endodontic climax communities of the Oral cavity: An extensive in-vitro study. Journal of Oral and maxillofacial. Pathology. 2019;23:407-411. DOI: 10.4103/jomfp.JOMFP_3_18
  25. 25. Bekiares N, Krueger CG, Meudt JJ, Shanmuganayagam D, Reed JD. Effect of sweetened dried cranberry consumption on urinary proteome and fecal microbiome in healthy human subjects. OMICS. 2018;22:145-153. DOI: 10.1089/omi.2016.0167
  26. 26. Khoo C, Duysburgh C, Marzorati M, van den Abbeele P, Zhang D. A freeze-dried cranberry powder consistently enhances SCFA production and lowers abundance of opportunistic pathogens in vitro. Biotech. 2022;2022:11. DOI: 10.3390/biotech11020014
  27. 27. Li Z, Ma J, Guo Y, Liu W, Li M, Zhang L, et al. Suppression of helicobacter pylori infection by daily cranberry intake: A double-blind, randomized, placebo-controlled trial. Journal of Gastroenterology and Hepatology. 2021;36:927-935. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246812/
  28. 28. Montorsi F, Gandaglia G, Salônia A, Briganti A, Mirone V. Effectiveness of a combination of cranberries, lactobacillus rhamnosus, and vitamin C for the Management of Recurrent Urinary Tract Infections in women: Results of a pilot study. European Urology. 2016;70:912-915. https://www.sciencedirect.com/science/article/abs/pii/S0302283816302500
  29. 29. Simoes L, Souza L. Avaliação in vitro da atividade antibacteriana de sucos de cranberry (Vaccinium macrocarpon) sobre cepas de Escherichia coli responsáveis por infecção urinária. Maringá PR. 2018. https://docs.bvsalud.org/biblioref/2019/11/1024973/rbacvol-51-2-2019-ref-745.pdf
  30. 30. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature Reviews. Microbiology. 2015;13:269-284. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457377/
  31. 31. Tamadonfar KO, Omattage NS, Spaulding CN, Hultgren SJ. Reaching the end of the line: Urinary tract infections. Microbiol. espectro. 2019;7:1-16. https://journals.asm.org/doi/10.1128/microbiolspec.BAI-0014-2019?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
  32. 32. Ventura J. Infecção do trato urinário por Escherichia coli resistente a antibióticos tratados com Vaccinum macrocarpon: relato de caso. http://rpmi.pe/ojs/index.php/RPMI/article/view/19/1
  33. 33. Jagannathan V, Viswanathan P. Proanthocyanidins— Proanthocyanidins—Will they effectively restrain conspicuous bacterial strains devolving on urinary tract infection? ? Journal of Basic Microbiology. 2018;58:567-578. https://onlinelibrary.wiley.com/doi/10.1002/jobm.201800131
  34. 34. Beerepoot M, Geerlings S. Non-antibiotic prophylaxis for urinary tract infections . 2016; 5:36. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931387/
  35. 35. Salo J, Uhari M, Helminen M, Korpi M, Nieminem J, Pokka T, Kontiokari T. Cranberry Juice for the Prevention of Recurrences of Urinary Tract Infections in Children: A Randomized Placebo-Controlled Trial. 2012. https://academic.oup.com/cid/article/54/3/340/302662?login=false
  36. 36. Maki KC, Kaspar KL, Khoo C, Derrig LE, Filho AL, Gupta K. Consumption of a cranberry juice beverage lowered the number of clinical urinary tract infection episodes in women with a recent history of urinary tract infection. American Journal of Clinical Nutrition. 2016;103:1434-1442. https://academic.oup.com/ajcn/article/103/6/1434/4569625?login=
  37. 37. Takahashi S, Hamasuna R, Yasuda M, Arakawa S, Tanaka K, Ishikawa K, et al. A randomized clinical trial to evaluate the preventive effect of cranberry juice (UR65) for patients with recurrent urinary tract infection. Journal of Infection and Chemotherapy. 2013;19:112-117. Disponível em: https://pubmed.ncbi.nlm.nih.gov/22961092/
  38. 38. Vasileiou UE, Katsargyris UMA, Theocharis S, Giaginis C. Current clinical status on the preventive effects of cranberry consumption against urinary tract infections. Nutrition Research. 2013;33:595-607. https://pubmed.ncbi.nlm.nih.gov/23890348/
  39. 39. Singh I, Gautam LK, Kaur IR. Effect of oral cranberry extract (standardized proanthocyanidin-A) in patients with recurrent UTI by pathogenic E. coli: A randomized placebo-controlled clinical research study. International Urology and Nephrology. 2016;48:1379-1386. https://pubmed.ncbi.nlm.nih.gov/27314247/
  40. 40. de Llano G, Liu H, Khoo C, Moreno-Arribas MV, Bartolomé B. Some new findings regarding the antiadhesive activity of cranberry phenolic compounds and their microbial-derived metabolites against Uropathogenic Bacteria. Journal of Agricultural Química Alimentar. 2019;67:2166-2174. https://pubs.acs.org/doi/10.1021/acs.jafc.8b05625
  41. 41. Samarasinghe S, Reid R, Al-Bayati M. The anti-virulence effect of cranberry active compound proanthocyanins (PACs) on expression of genes in the third-generation cephalosporin-resistant Escherichia coli CTXM-15 associated with urinary tract infection. 2019. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865039/

Written By

Gabriela Cimadon, Sabrina Barili, Alana da Silva and Beatriz Bonadiman

Submitted: 22 December 2022 Reviewed: 28 January 2023 Published: 28 March 2023